MedPath

Improvement of physical abilities in patients with cystinosis

Phase 1
Completed
Conditions
Improvement of cardiorespiratory performance and muscle strength in patients with cystinosis
Genetic Diseases
Registration Number
ISRCTN15626850
Lead Sponsor
Cystinose Stiftung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Confirmed diagnosis of infantile nephropathic cystinosis
2. Prepubertal patients from 6 to 13 years of age or from the age of 18
3. Consent of the patient (18 years and older) or legal representative (for minors)

Exclusion Criteria

1. Patients who are likely to undergo a serious intervention (e.g. kidney transplant, orthopedic surgery) during the duration of the study or for whom there are contraindications for training on Galileo vibration platforms according to the official recommendation
2. Adolescents who have started puberty (boys: testicular volume 3 ml, girls: Tanner stage from B2). Since puberty in these patients starts late, the prepubertal age group was extended to the age of 13 years. The pubertal age group was excluded due to the hormonal changes during this period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath